secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001628280-25-037582
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem Q2 net revenue $36M (+7% YoY); net income up 262% to $2.6M; raises FY25 EBITDA margin guidance to 20%+
--------------------------------------------------------------------------------

- Net revenue $36.0M (+7% YoY); Patient Services $21.5M (+6%), Device Solutions $14.5M (+8%).
- Net income $2.6M ($0.12 diluted EPS) vs $0.7M ($0.03) prior year; Adjusted EBITDA $8.0M (+32%).
- Gross margin expanded 5.7 pts to 55.2%; YTD operating cash flow $8.8M (up 227%).
- FY25 revenue growth guidance lowered to 6-8% (from 8-10%), but Adjusted EBITDA margin raised to 20%+ (from 18.8%+).
- Repurchased $3.5M of stock in Q2; acquired a small company for $1.4M to improve Advanced Wound Care processing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025037582/0001628280-25-037582-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025037582/infu-20250805.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-037582

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer